Načítá se...
Pharmacogenomics in Heart Failure: Where Are We Now and How Can We Reach Clinical Application
Heart failure is becoming increasingly prevalent in the United States and is a significant cause of morbidity and mortality. Several therapies are currently available to treat this chronic illness; however, clinical response to these treatment options exhibit significant interpatient variation. It i...
Uloženo v:
| Vydáno v: | Cardiol Rev |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4329642/ https://ncbi.nlm.nih.gov/pubmed/25093738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CRD.0000000000000028 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|